2024 Bcel stock forecast - 2010. 90. John Orwin. https://www.atreca.com. Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified ...

 
Atreca, Inc. (BCEL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock .... Bcel stock forecast

The latest Atreca stock prices, stock quotes, news, and BCEL history to help you invest and trade smarter. ... The 11 analysts offering price forecasts for Atreca have a median target of 11.77 ...BCEL Earnings Date and Information. Atreca last posted its quarterly earnings data on May 10th, 2023. The reported ($0.54) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.56) by $0.02. Atreca has generated ($2.18) earnings per share over the last year ( ($2.18) diluted earnings per share).Competitors. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 30,387.50, with a high estimate of 30,387.50 and a low estimate of ...11.30% of Atreca stock is owned by insiders. Which Atreca insiders have been selling company stock? The following insiders have sold BCEL shares in the last 24 months: Bros. Advisors Lp Baker ($109,895.60), John A Orwin ($37,216.24), Phillips Courtney ($15,321.16), and Tito Serafini ($199,122.53).HOOK Stock 12 Months Forecast. $6.83. (1382.20% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Hookipa Pharma in the last 3 months. The average price target is $6.83 with a high forecast of $7.00 and a low forecast of $6.50. The average price target represents a 1382.20% change from the last price of $0.46.According to the issued ratings of 5 analysts in the last year, the consensus rating for Atreca stock is Hold based on the current 4 hold ratings and 1 buy rating for …This reflects a positive earnings surprise of 12.50%. Look out for BCEL's next earnings release expected on November 09, 2023. For the next earning release, we expect the company to report ... Dec 1, 2023 · Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. Science. Atreca Inc (NASDAQ:BCEL)’s traded shares stood at 0.33 million during the last session, with the company’s beta value hitting 1.24. At the close of trading, the stock’s price was $0.21. The BCEL share’s 52-week high remains $2.05, putting it -876.19% down since that peak but still an impressive 9.52% since price per share fell ...Find the latest ADMA Biologics, Inc. (ADMA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for Atreca stock is $3.38, which predicts an increase of 1,472.09%. The lowest target is $1.00 and the highest is $10. On average, analysts rate Atreca stock as a hold.Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Nu Holdings Ltd have a median target of 9.75, with a high estimate of 16.00 and a low estimate of 6.00. The median ...Science. Atreca Inc (NASDAQ:BCEL)’s traded shares stood at 0.33 million during the last session, with the company’s beta value hitting 1.24. At the close of trading, the stock’s price was $0.21. The BCEL share’s 52-week high remains $2.05, putting it -876.19% down since that peak but still an impressive 9.52% since price per share fell ...The Atreca Inc. stock price gained 5.36% on the last trading day (Friday, 17th Nov 2023), rising from $0.209 to $0.220. During the last trading day the stock fluctuated 9.33% from a day low at $0.210 to a day high of $0.230. The price has been going up and down for this period, and there has been a -16.59% loss for the last 2 weeks.Stock Price Forecast. The 4 analysts offering 12-month price forecasts for SilverBow Resources Inc have a median target of 55.00, with a high estimate of 67.00 and a low estimate of 50.00. The ...Shares in Artego SA last closed at RON15.30 and the price had moved by +23.39% over the past 365 days. In terms of relative price strength the Artego SA share price has outperformed the FTSE Global All Cap Index by +15.74% over the past year.Apr 6, 2023 · Shares of Atreca, Inc. (BCEL) have been struggling lately and have lost 20% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the ... Nasdaq +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Atreca, Inc. (BCEL) NasdaqGS - NasdaqGS Real Time Price. Currency in USD... Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for Atreca stock is $3.38, which predicts an increase of 1,509.52%. …Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Nu Holdings Ltd have a median target of 9.75, with a high estimate of 16.00 and a low estimate of 6.00. The median ... This reflects a positive earnings surprise of 12.50%. Look out for BCEL's next earnings release expected on November 09, 2023. For the next earning release, we expect the company to report ... Earnings vs Market: BCEL is forecast to remain unprofitable over the next 3 years. High Growth Earnings : BCEL is forecast to remain unprofitable over the next 3 …Aug 7, 2023 · BCEL stock forecast Our latest prediction for Atreca Inc's stock price was made on the Aug. 7, 2023 when the stock price was at 0.91$. In the short term (2weeks), BCEL's stock price should underperform the market by -3.07%. During that period the price should oscillate between -9.61% and +7.63%. Competitors. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 30,387.50, with a high estimate of 30,387.50 and a low estimate of ...Atreca Inc (BCEL) Stock Price & News - Google Finance Home BCEL • NASDAQ Atreca Inc Follow Share $0.21 After Hours: $0.22 (2.90%) +0.0062 Closed: Nov 24, 3:00:17 PM GMT-5 · USD · NASDAQ ·...Find real-time CBAY - CymaBay Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Stock Price Forecast. The 20 analysts offering 12-month price forecasts for Kroger Co have a median target of 51.75, with a high estimate of 65.00 and a low estimate of 37.00. The median estimate ...Nov 29, 2023 · Based on short-term price targets offered by four analysts, the average price target for Atreca, Inc. comes to $5.25. The forecasts range from a low of $1.00 to a high of $10.00. The average price ... The rating of the stock has changed to hold according to some analysts. It's at an all time low, buy folks thanks me later. Recently BCEL has reached an all time low and a data suggests that is will rise back up. According to Fintel.IO Blackrock has bought a staggering 350k shares. The rating of the stock has changed to hold according to some ...Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now Zacks - Thu Apr 6, 8:55AM CDT . Atreca, Inc. (BCEL) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall...Cymabay Therapeutics Inc () Stock Market info Recommendations: Buy or sell Cymabay Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cymabay Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Cymabay Therapeutics's CBAY shares and potentially …NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Find the latest Keurig Dr Pepper Inc. (KDP) stock quote, history, news and other vital information to help you with your stock trading and ...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Based on 10 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $24.40 with a high forecast of $33.00 and a low forecast of $20.00. The average price target represents a 29.93% change from the last price of $18.78. Highest Price Target $33.00. Average Price Target $24.40.Nov 6, 2023 · BCEL Stock Predictions, Articles, and Atreca Inc Cl A News From InvestorPlace From the Web 3 Penny Stocks to Catapult You Into the Millionaires’ Club By Omor Ibne Ehsan Jul 13, 2023 ... Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.Patterson-UTI Energy Inc () Stock Market info Recommendations: Buy or sell Patterson-UTI Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Patterson-UTI Energy share forecasts, stock quote and buy / sell signals below.According to present data Patterson-UTI Energy's PTEN shares and potentially …CRNT Earnings Forecast. Next quarter’s earnings estimate for CRNT is $0.06 with a range of $0.06 to $0.06. The previous quarter’s EPS was $0.06. CRNT beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 66.36% of the time in the same period. In the last calendar year CRNT has ...Performance Outlook. Short Term. 2W - 6W. Mid Term. 6W - 9M. Long Term. 9M+ Previous Close: 0.2197 ... Stock Falls 37%. Atreca (BCEL) suspends the development of only pipeline candidate, ATRC-101 ...5 equities research analysts have issued twelve-month target prices for Atreca's stock. Their BCEL share price targets range from $4.00 to $25.00. On average, they expect the company's stock price to reach $10.75 in the next twelve months. This …May 10, 2023 · On May 10, 2023, Atreca (NASDAQ:BCEL) announced its financial results for the first quarter of the year. The company reported Atreca Reports Q1 2023 Financial Results with Exceeding Analyst Estimates - Best Stocks Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Atreca Inc have a median target of 1.50, with a high estimate of 9.00 and a low estimate of 1.00. The median estimate represents a +500.00% increase from the last price of 0.25.Li Auto Inc - ADR Stock Forecast, LI stock price prediction. Price target in 14 days: 44.695 USD. The best long-term & short-term Li Auto Inc - ADR share price ... QFIN Stock 12 Months Forecast. $25.75. (85.12% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Qifu Technology in the last 3 months. The average price target is $25.75 with a high forecast of $27.00 and a low forecast of $24.50. The average price target represents a 85.12% change from the last price of $13.91.According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.NSD:BCEL Detailed Stock Analysis, Stock Price Forecast, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes. About Us ... Based on the Atreca Inc stock forecast from 3 analysts, the average analyst target price for Atreca Inc is USD 1.00 over the next 12 months.In 2021 and 2020, respectively 14 and 13 companies raised sums of $250m or more, whilst in 2019 and 2018, the numbers were 3 and 2. Atreca Inc ( NASDAQ: BCEL) IPOd in June 2019, raising ~$114m at ...The stock market is getting a jolt from the inflation report. All three major U.S. stock indexes jumped more than 1% Tuesday morning, with the coming close to a 2% gain.The current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.BCEL reported Q4'22 and full year earnings on March 29. Cash, cash equivalents and investments were $70.5M at the end of 2022. R&D expenses were $66.8M for 2022 and G&A expenses were $31.5M for ...Analyst projections state that BCEL is forecast to be at a low of $1.00 and a high of $9.00. In order for the stock price to hit the forecast high, the stock would need to plunge -3361.54% from its current level, while the stock would need to crash -284.62% from its current level to reach the projected low. Atreca Inc (BCEL) estimates and forecastsNasdaq +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Atreca, Inc. (BCEL) NasdaqGS - NasdaqGS Real Time Price. Currency in USD... Over the last year, the company’s stock hit its highest at $2.05 on 01/31/23, while the lowest price during the same time frame was $0.21, recorded on 10/09/23. 52-week price history of BCEL Stock. The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential.The average Qifu Technology stock price prediction forecasts a potential upside of 57.86% from the current QFIN share price of $15.52. What is QFIN's forecast return on equity (ROE) for 2023-2025? (NASDAQ: QFIN) forecast ROE is N/A, which is considered weak.Complete Atreca Inc. Cl A stock information by Barron's. View real-time BCEL stock price and news, along with industry-best analysis.2010. 90. John Orwin. https://www.atreca.com. Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified ...The consensus price target of analysts on Wall Street is $2.00, which implies an increase of 89.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.00 and $2.00 respectively. As a result, BCEL is trading at a discount of -809.09% off the target high and -809.09% off the low.Forecst.com predicts future values using technical analysis of a large number of analytical parameters. BCLI stock returns are also predicted based on historical data. According to our research, BCLI stock is a bad long-term investment. BCLI share price has been in a bear cycle for the past year.Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Hudbay Minerals share forecasts, stock quote and buy / sell signals below. According to present data Hudbay Minerals's HBM shares and potentially its market environment have been in bearish cycle last 12 months (if exists).The latest Atreca stock prices, stock quotes, news, and BCEL history to help you invest and trade smarter. ... The 11 analysts offering price forecasts for Atreca have a median target of 11.77 ...The Atreca stock forecast for tomorrow is $ 0.213730, which would represent a -4.16% loss compared to the current price. In the next week, the price of BCEL is expected to decrease by -24.67% and hit $ 0.167988. As far as the long-term Atreca stock forecast is concerned, here’s what our ... Stock Price Forecast. The 20 analysts offering 12-month price forecasts for Kroger Co have a median target of 51.75, with a high estimate of 65.00 and a low estimate of 37.00. The median estimate ...BCEL stock forecast Our latest prediction for Atreca Inc's stock price was made on the Aug. 7, 2023 when the stock price was at 0.91$. In the short term (2weeks), BCEL's stock price should underperform the market by -3.07%. During that period the price should oscillate between -9.61% and +7.63%.Century Aluminum Co. () Stock Market info Recommendations: Buy or sell Century Aluminum stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Century Aluminum share forecasts, stock quote and buy / sell signals below.According to present data Century Aluminum's CENX shares and potentially its …Find the latest Morphic Holding, Inc. (MORF) stock quote, history, news and other vital information to help you with your stock trading and investing.Atreca Stock Forecast and Price Target. According to six esteemed experts, the average price target for Atreca to reach this year is $17.00, with a potential upside of …Atreca Inc [BCEL] stock prices are down -14.82% to $0.28 at the moment. ... An investor can expect a potential return of 1060.71% based on the average BCEL price forecast. Analyzing the BCEL fundamentals. In this publicly-traded organization, revenue per employee is $8,556, ...Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business.Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 13.00, with a high estimate of 13.00 and a low estimate of 13.00. The ...VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83.ATRECA, INC. stock price forecast for further price development down to -100.00% (time horizon: 1 day) and price target of 0.00 USD. Negative news sentiment. Short-term (time horizon: 2 weeks) ATRECA, INC. share price prediction for 2024-01-12 with daily closed price projectionsBCEL is currently rated as a Sucker Stock | Stockopedia. Login Get Started. Sectors Healthcare Biotechnology & Medical Research Atreca. ... Is there a Atreca share price forecast for 2023? The analyst consensus target price for shares in Atreca is $3.25. That is 1420.11% above the last closing price of $0.21.Nov 23, 2023 · Science. Atreca Inc (NASDAQ:BCEL)’s traded shares stood at 0.33 million during the last session, with the company’s beta value hitting 1.24. At the close of trading, the stock’s price was $0.21. The BCEL share’s 52-week high remains $2.05, putting it -876.19% down since that peak but still an impressive 9.52% since price per share fell ... According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.Atreca, Inc. : Forcasts, revenue, earnings, analysts expectations, ratios for Atreca, Inc. Stock | BCEL | US04965G1094The average Qifu Technology stock price prediction forecasts a potential upside of 57.86% from the current QFIN share price of $15.52. What is QFIN's forecast return on equity (ROE) for 2023-2025? (NASDAQ: QFIN) forecast ROE is N/A, which is considered weak.Stock Price Forecast. The 17 analysts offering 12-month price forecasts for BCE Inc have a median target of 41.19, with a high estimate of 45.64 and a low estimate of 39.16. The median estimate ...Nov 30, 2023 · Atreca, Inc. (BCEL.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atreca, Inc. | Nasdaq: BCEL | Nasdaq Stock Price Forecast. The 20 analysts offering 12-month price forecasts for Kroger Co have a median target of 51.75, with a high estimate of 65.00 and a low estimate of 37.00. The median estimate ...Last reporting date. November 13, 2023. EPS forecast (this quarter) -$68.00. Annual revenue (last year) $1.1B. Annual profit (last year) -$415.6M. Net profit margin.5 equities research analysts have issued twelve-month target prices for Atreca's stock. Their BCEL share price targets range from $4.00 to $25.00. On average, they expect the company's stock price to reach $10.75 in the next twelve months. This …A treca, Inc. (BCEL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...Detailed statistics for Atreca, Inc. (BCEL) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for Atreca, Inc. (BCEL) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The average price target for Atreca is $3.38, which is 1,415.70% ...Find the latest Atreca, Inc. (BCEL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Bcel stock forecast

Atreca is forecast to grow earnings and revenue by 10.3% and 9.5% per annum respectively while EPS is expected to grow by 30.2% per annum.. Bcel stock forecast

bcel stock forecast

12 brokerages have issued 1-year price targets for CymaBay Therapeutics' stock. Their CBAY share price targets range from $12.00 to $34.00. On average, they expect the company's stock price to reach $22.27 in the next twelve months. This suggests a possible upside of 13.0% from the stock's current price. View analysts price targets for …Competitors. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 30,387.50, with a high estimate of 30,387.50 and a low estimate of ... With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.The 360 Finance, Inc. stock price fell by -2.78% on the last day (Wednesday, 22nd Nov 2023) from $16.53 to $16.07. During the last trading day the stock fluctuated 4.68% from a day low at $15.81 to a day high of $16.55. The price has risen in 6 of the last 10 days and is up by 4.15% over the past 2 weeks.Cymabay Therapeutics Inc () Stock Market info Recommendations: Buy or sell Cymabay Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cymabay Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Cymabay Therapeutics's CBAY shares and potentially …Read more about BCEL’s peers. A high-level overview of Atreca, Inc. (BCEL) stock. Stay up to date on the latest stock price, chart, news, analysis, …Learn more about Atreca Inc's (BCEL) stock grades for Momentum, Growth and Estimate Revisions and determine whether this Biotechnology & Medical Research stock meets your investment needs. ... The Biotechnology and Medical Research sub-industry has a positive outlook, a historically defensive sub-industry. Drug sales are …In 2021 and 2020, respectively 14 and 13 companies raised sums of $250m or more, whilst in 2019 and 2018, the numbers were 3 and 2. Atreca Inc ( NASDAQ: BCEL) IPOd in June 2019, raising ~$114m at ...msn.com - August 11 at 5:24 PM. Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring. finance.yahoo.com - August 11 at 12:47 AM. Atreca Inc - (BCEL) Price Target Increased by 11.89% to 10.20. msn.com - August 2 at 12:44 PM. Atreca Approaches A Major Go/No-Go Decision.The stock market is getting a jolt from the inflation report. All three major U.S. stock indexes jumped more than 1% Tuesday morning, with the coming close to a 2% gain.Find the latest ADMA Biologics, Inc. (ADMA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Find the latest Keurig Dr Pepper Inc. (KDP) stock quote, history, news and other vital information to help you with your stock trading and ...Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for Atreca stock is $3.38, which predicts an increase of 1,472.09%. The lowest target is $1.00 and the highest is $10. On average, analysts rate Atreca stock as a hold.Dec 2, 2023 · The consensus price target of analysts on Wall Street is $2.00, which implies an increase of 89.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.00 and $2.00 respectively. As a result, BCEL is trading at a discount of -809.09% off the target high and -809.09% off the low. Price target. 3.25 0.00 0.00%. The 4 analysts offering 1 year price forecasts for BCEL have a max estimate of — and a min estimate of —.May 6, 2023 · Atreca Stock Forecast and Price Target. According to six esteemed experts, the average price target for Atreca to reach this year is $17.00, with a potential upside of approximately 1,600%. This prediction is based on a high estimate of $35.00 and a low estimate of $11.00. Analyst Ratings of ATRECA INC - A(NASDAQ:BCEL) stock. Analyst ratings, forecast, price target, upgrades and ... Analysts have set a mean price target forecast of 3.32. This target is 1406.82 ... seem to be have mildly positive about BCEL. In the previous month the buy percentage consensus was at a similar level. BCEL was analyzed by 13 analysts ...Turning Spencer's outlook into concrete recommendations, Baird analyst Joel Beatty is pounding the table on two stocks that look especially compelling. According to the analyst, each name is ...Atreca Inc Cl A (BCEL) Company Description. Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism ...2010. 90. John Orwin. https://www.atreca.com. Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified ...The current average BCEL price target, as estimated by these analysts, is $4.00. The predictions for the future BCEL stock price range from a low of $4.00 to a high of $4.00, highlighting the variability of market expectations for BCEL.See Atreca, Inc. (BCEL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Analyst Forecast. According to 5 analysts, the average rating for BCEL stock is "Hold." The 12-month stock price forecast is $3.38, which is an increase of …BANQUE POUR LE COMMERCE EXTERIEUR LAO PUBLIC. Date: Previous day: Opening : Last: Change: Change (%) High: Low: Trading Volume (shr) Trading Value (LAK)Based on short-term price targets offered by four analysts, the average price target for Atreca, Inc. comes to $5.25. The forecasts range from a low of $1.00 to a high of $10.00. The average price ...Atreca, Inc. Class A Common Stock (BCEL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Find the latest Morphic Holding, Inc. (MORF) stock quote, history, news and other vital information to help you with your stock trading and investing.Atreca, Inc. (BCEL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...The shares of micro-cap biotech, Atreca (BCEL +46.1%) have added more than a third in morning hours on Friday after the company updated early-stage data for its lead cancer candidate ATRC-101 with ...Atreca, Inc. Class A Common Stock (BCEL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.The average one-year price target for BCEL / Atreca Inc - Class A is $3.315. The forecasts range from a low of $1.01 to a high of $9.45. A stock’s price target is the price at which analysts consider it fairly valued with respect to its …Read Full Company Summary for BCEL here. View Atreca, Inc BCEL investment & stock information. Get the latest Atreca, Inc BCEL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.October 13, 2023. At the time of writing, Atreca Inc [BCEL] stock is trading at $0.38, up 61.06%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BCEL shares have gain 66.93% over the last week, with a monthly amount glided 11.79%, and seem to be holding up well over a long-time horizon.According to the issued ratings of 9 analysts in the last year, the consensus rating for Hudbay Minerals stock is Moderate Buy based on the current 2 hold ratings and 7 buy ratings for HBM. The average twelve-month price prediction for Hudbay Minerals is C$9.18 with a high price target of C$10.50 and a low price target of C$8.00.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.BCEL Earnings Date and Information. Atreca last posted its quarterly earnings data on May 10th, 2023. The reported ($0.54) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.56) by $0.02. Atreca has generated ($2.18) earnings per share over the last year ( ($2.18) diluted earnings per share).Based on analysts offering 12 month price targets for BCEL in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .Atreca Stock Forecast and Price Target. According to six esteemed experts, the average price target for Atreca to reach this year is $17.00, with a potential upside of approximately 1,600%. This prediction is based on a high estimate of $35.00 and a low estimate of $11.00.May 10, 2023 · On May 10, 2023, Atreca (NASDAQ:BCEL) announced its financial results for the first quarter of the year. The company reported Atreca Reports Q1 2023 Financial Results with Exceeding Analyst Estimates - Best Stocks See Atreca, Inc. (BCEL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Based on analysts offering 12 month price targets for BCEL in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Atreca Inc Cl A stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction. ... BCEL Related stocks. Symbol 3M %Chg ; BCEL -64.18% : Atreca Inc Cl A: AMGN +16. ...NSD:BCEL Detailed Stock Analysis, Stock Price Forecast, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes. About Us ... Based on the Atreca Inc stock forecast from 3 analysts, the average analyst target price for Atreca Inc is USD 1.00 over the next 12 months.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Li Auto Inc - ADR share forecasts, stock quote and buy / sell signals below. According to present data Li Auto Inc - ADR's LI shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).The latest Atreca stock prices, stock quotes, news, and BCEL history to help you invest and trade smarter. ... The 11 analysts offering price forecasts for Atreca have a median target of 11.77 ...Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response.HOOK Stock 12 Months Forecast. $6.83. (1382.20% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Hookipa Pharma in the last 3 months. The average price target is $6.83 with a high forecast of $7.00 and a low forecast of $6.50. The average price target represents a 1382.20% change from the last price of $0.46.Atreca, Inc. (BCEL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...BCEL is currently rated as a Sucker Stock | Stockopedia. Login Get Started. Sectors Healthcare Biotechnology & Medical Research Atreca. ... Is there a Atreca share price forecast for 2023? The analyst consensus target price for shares in Atreca is $3.25. That is 1420.11% above the last closing price of $0.21.5 equities research analysts have issued twelve-month target prices for Atreca's stock. Their BCEL share price targets range from $4.00 to $25.00. On average, they expect the company's stock price to reach $10.75 in the next twelve months. This suggests a possible upside of 4,474.5% from the stock's current price.Dec 1, 2023 · Their VKTX share price targets range from $19.00 to $37.00. On average, they predict the company's stock price to reach $30.25 in the next twelve months. This suggests a possible upside of 132.5% from the stock's current price. View analysts price targets for VKTX or view top-rated stocks among Wall Street analysts. Nov 6, 2023 · Analyst projections state that BCEL is forecast to be at a low of $1.00 and a high of $9.00. In order for the stock price to hit the forecast high, the stock would need to plunge -3361.54% from its current level, while the stock would need to crash -284.62% from its current level to reach the projected low. Atreca Inc (BCEL) estimates and forecasts Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 5.50, with a high estimate of 9.00 and a low estimate of 2.50. The median ...🚀 Atreca stock price forecast: $4; Market Cap: 11.00M, Enterprise value: 68.43M, P/E: -0.4, PEG ratio: -0.03, EPS: -2.11, Revenue: N/A, EBITDA: -81.73M, Income ...Find real-time NU - Nu Holdings Ltd stock quotes, company profile, news and forecasts from CNN Business.BCEL BCEL Atreca Inc - Ordinary Shares - Class A 2,464 Watch Alerts $0.223 $0.0092 (4.30%) Today $0.23 0.0035 (1.57%) After Hours About Feed News Sentiment Earnings …Dec 1, 2023 · Atreca, Inc. - Hold. Zacks' proprietary data indicates that Atreca, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the BCEL shares relative to the market in ... If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.ALEC Stock 12 Months Forecast. $13.78. (169.14% Upside) Based on 9 Wall Street analysts offering 12 month price targets for Alector in the last 3 months. The average price target is $13.78 with a high forecast of $41.00 and a low forecast of $4.00. The average price target represents a 169.14% change from the last price of $5.12.The BCEL shares have gain 4.62% over the last week, with a monthly amount glided 4.62%, and seem to be holding up well As of right now, Atreca Inc [BCEL] is trading at $0.22, up 2.19%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value.Find the latest Atreca, Inc. (BCEL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Nov 30, 2023 · The Atreca Inc. stock price gained 5.36% on the last trading day (Friday, 17th Nov 2023), rising from $0.209 to $0.220. During the last trading day the stock fluctuated 9.33% from a day low at $0.210 to a day high of $0.230. The price has been going up and down for this period, and there has been a -16.59% loss for the last 2 weeks. Competitors. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 30,387.50, with a high estimate of 30,387.50 and a low estimate of ...$191.45 +1.76 +0.93% Find the latest analyst research for Atreca, Inc. Class A Common Stock (BCEL) at Nasdaq.com.Stock Price Forecast. The 31 analysts offering 12-month price forecasts for Li Auto Inc have a median target of 51.77, with a high estimate of 81.63 and a low estimate of 35.76. The median ...The average Qifu Technology stock price prediction forecasts a potential upside of 57.86% from the current QFIN share price of $15.52. What is QFIN's forecast return on equity (ROE) for 2023-2025? (NASDAQ: QFIN) forecast ROE is N/A, which is considered weak.QFIN Stock 12 Months Forecast. $25.75. (85.12% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Qifu Technology in the last 3 months. The average price target is $25.75 with a high forecast of $27.00 and a low forecast of $24.50. The average price target represents a 85.12% change from the last price of $13.91.Last reporting date. November 13, 2023. EPS forecast (this quarter) -$68.00. Annual revenue (last year) $1.1B. Annual profit (last year) -$415.6M. Net profit margin.Earnings announcement* for BCEL: Our vendor, Zacks Investment Research, hasn't provided us with the upcoming earnings report date. BCEL has a "high" Earnings Quality Ranking (EQR) for the 5th ... This reflects a positive earnings surprise of 12.50%. Look out for BCEL's next earnings release expected on November 09, 2023. For the next earning release, we expect the company to report ... . Vinfast stoc